MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Oct 8, 02:26 PM (EDT)
Price
$6.84
Change
+$0.10 (+1.48%)
Capitalization
252.52M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Oct 07, 2025

LFCR in upward trend: price may jump up because it broke its lower Bollinger Band on September 10, 2025

LFCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where LFCR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on September 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

LFCR moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LFCR crossed bearishly below the 50-day moving average on October 01, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LFCR entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LFCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LFCR's P/B Ratio (188.679) is slightly higher than the industry average of (18.744). P/E Ratio (51.231) is within average values for comparable stocks, (73.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.989). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.821) is also within normal values, averaging (47.108).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to rise 158.33% to -15 cents per share on January 01

Lifecore Biomedical LFCR Stock Earnings Reports
Q4'25
Est.
$-0.16
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.04
The last earnings report on August 07 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 33.98K shares outstanding, the current market capitalization sits at 252.52M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFXTF0.20N/A
N/A
Conifex Timber Inc.
LNSPF2.45N/A
N/A
London & Stamford Property PLC
BLUAF10.90N/A
N/A
BlueRiver Acquisition Corp.
HLBZF215.16-10.13
-4.50%
HEIDELBERG MATERIALS AG
FPLSF12.48-0.62
-4.73%
5N Plus, Inc.

LFCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.61%
NBIX - LFCR
36%
Loosely correlated
-1.74%
SHPH - LFCR
31%
Poorly correlated
-2.55%
ALKS - LFCR
30%
Poorly correlated
-0.13%
AMRX - LFCR
30%
Poorly correlated
-1.80%
PBH - LFCR
28%
Poorly correlated
-0.51%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.61%
Pharmaceuticals: Generic
industry (222 stocks)
29%
Poorly correlated
+0.45%